Home Analyst Ratings Cimarex Energy Stock Gets Reiterated At KeyBanc. It's Still Overweight

Cimarex Energy [XEC] Stock Gets Reiterated At KeyBanc. It’s Still Overweight

KeyBanc maintained its Cimarex Energy [XEC] rating to the equivalent of Overweight but changed the price target to $$46.0 from $42, in a research note dated 2021-01-07. That figure represents around a 5.89% premium from where the company’s shares closed on Wednesday. Other analysts also revised their coverage, with Trust’ analysts downgrading the shares from “a Buy” rating to “a Hold” rating in a research note to investors issued in early December. Meanwhile, Raymond James had raised its rating on XEC to “an Outperform” from the earlier “Mkt perform”, in a research note produced for clients on October 21, 2020. In addition, there was an upgrade from Truist on October 13, 2020. The rater changed XEC from “a Hold” to “a Buy”.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Is Cimarex Energy Co. [NYSE:XEC] a Good Buy Right Now?

It should be noted that XEC technical indicators for short, intermediate as well as long term progress have placed an overall average of 100% as Buy. The average signal changed from 88% Buy in the last week and compares with 100% Buy in the past month. Data from Cimarex Energy Co.’s Trend Spotter indicated that the signals were Strongest. The stock current average is 1.22 million shares in the past 20 days and the short term average signal indicates a 100% Buy. In the last 50 days, the average trading volume was 1.48 million shares while the medium-term average advocated for 100% Buy. The average long-term signal stands at 100% Buy and the 100-day average volume stands at 1.46 million shares.


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


XEC Price Performance

On Wall Street, Cimarex Energy Co. [NYSE:XEC] finished Wednesday’s session up 4.62% at $43.45. The stock went up to $43.49 at the same session while its lowest single-day price was $41.4873. In the last five days, it saw a rise of about 17.02%, Cimarex Energy Co. shares gained by almost 15.84% since the beginning of the year. However, the share price has dropped to as low as -21.41% below its one year high. On 01/06/21, the company shares recorded $43.49, the highest single-day price it has got to in the last 52-weeks, and a 52-week low was seen on 01/04/21, the same year at $37.59. The company’s shares have declined by -21.19% in the past year. The 50-day SMA achieved is $34.80 while the 200-day SMA is $27.59. Volume dropped to 1.75 million from 1.86 million in the previous session.

XEC Stock Support And Resistance Levels

On the 24-hour scale, the immediate backing is perceived around 42.13 level, and in case of violation of this particular level, it will cause more drop to 40.81 level. On the upper level, 44.81 is still the key resistance. The stock may increase to the subsequent resistance at 44.13. The Relative Strength Index (RSI) pinned on the 14-day chart is 70.96, implying an overbought technical stance while the MACD stands at 2.34, meaning price will increase in the next trading period. Percent R indicator moved to 0.58%, implying bullish price movement. Stochastic %K at 77.18% suggest selling the stock.

What is the short interest in Cimarex Energy Co.?

Short interest in the Cimarex Energy Co. stock has plunged, decreasing by -0.56 million shares to total 2.96 million shares on Dec 14, 2020. The interest had seen shares on Nov 12, 2020 stand at 2.4 million, data from Yahoo Finance shows. The increase of 18.92% suggests the stock saw some increased bearish sentiment. The stock’s days to cover (short ratio) moved to while the shorted shares account for just 3.34% of the overall float for the stock.

Cimarex Energy Co.’s Biggest Shareholders: Who Owns Cimarex Energy Co. [XEC]?

Filings by The Vanguard Group, Inc. showed that the firm now holds a total of 10,002,051 shares or roughly 9.81% of the outstanding XEC shares. This means their shares have increased by 178,488 from the 10,002,051 the investor reportedly held in its prior 13-F filing. With the conclusion of the purchase, BlackRock Fund Advisors updated stake is worth $281,963,040. Details in the latest 13F filings reveal that SSgA Funds Management, Inc. disposed off their -16.50% stake valued at $163,709,002 while Victory Capital Management, Inc. added theirs at $151,545,715. During the last quarter, SSgA Funds Management, Inc. liquidated -900,145 of its shares in Cimarex Energy Co. while Victory Capital Management, Inc. bought 138,065 shares. The Diamond Hill Capital Management,’s holdings currently number 3,085,949 shares at $134084484.05. According to the firm’s last 13F report, Dimensional Fund Advisors LP shares in the company at filing stood at 2,587,880 shares, roughly $93,034,286.

XEC Earnings Forecast For The Current Quarter

Cimarex Energy Co. [XEC] is expected to report weak earnings results for the quarter ending in Dec 2020. Consensus estimates give the company expected revenues of $401.54M and earnings per share of $0.61 for Dec 2020. Looking further ahead, the company is expected to report revenue of $453.34M at an EPS of $0.88 for Mar 2021. The estimates represent a downside of 21.30% and 312.63% in the company’s revenue and earnings per share, respectively, on a year-on-year basis.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

XEC Earnings Estimates For The Current Year

For the financial year, Cimarex Energy Co. [NYSE:XEC] is expected to bring in revenue of $1.56B. The returns are nearly $-800.0 million lower than the company’s actual revenue recorded in the fiscal year 2019. In terms of EPS for the 2020, estimate put it at 0.94, lower than that of FY19 by -$3.52. Estimates put this year’s earnings growth at -78.90%, 313.80% for the next, and at an annual 14.72% over the next 5-year period. As for sales, forecasts are for a decrease of -34.10% in the current fiscal year and a further 21.30% over the following year.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

What Has Been Raising The Soleno (SLNO) Stock Up Before Market Open?

In recent premarket trading, Soleno Therapeutics Inc. (SLNO) has soared 3.77% at $1.10 per share. The Soleno stock closed at $1.06 yesterday, down -6.19%. Get...

Stealth BioTherapeutics Corp (MITO) Stock Going Down in PreMarket, Here’s What You Should Know

Stealth BioTherapeutics Corp (MITO) stock prices were up by a colossal 35% as of the market closing on May 6th, 2021, bringing the price...

Why Ocugen, Inc. (OCGN) stock is popping high today?

Shares of Ocugen, Inc. (OCGN) stock were popping high today on May 7, 2021, ahead of today’s earnings report.OCGN stock price saw a surge...

What Is Driving The Powerbridge (PBTS) Stock Higher In Premarket session?

At the last check, Powerbridge Technologies Co. Ltd. (NASDAQ: PBTS) shares were rising 10.71% to trade at $1.55 in premarket trades. The Powerbridge stock...

Beyond Meat, Inc. (BYND) Stock Trending Down After Management’s Uncertainty Over Fiscal Year Guidelines

Beyond Meat, Inc. (BYND) stock prices were down by 2.08% as of the market closing on May 6th, 2021, bringing the price per share...

Regional Health Properties, Inc. (RHE) Stock Skyrockets Following Trading of Exponential Volume of Shares

Regional Health Properties, Inc. (RHE) stock prices soared by 31.4% during early market hours on May 7th 2021, bringing the price per share up...

Orphazyme A/S (ORPH) Stock Plummeting After Failure of ORAIALS-01 Trial Announced

Orphazyme A/S (ORPH) stock prices plummeted by 27.77%  after the market opened on May 7th, 2021, bringing the price per share tumbling down to...

Avalon Holdings Corporation (NYSE:AWX) stock surged in the current trading session; here’s why

At last check, in the current trading session, AWX stock surged by 22.58% to $5.08. AWX stock previously closed the session at $4.14. The...

Related News

Ocugen Inc. (NASDAQ:OCGN) stock plunged in the premarket trading session; here’s why

At last check Ocugen Inc. (OCGN) stock had plunged by-11.92% to $9.61 in premarket trading session. OCGN stock previously closed at $10.91 losing -12.79%....

KeyBanc reiterates Magna International [MGA] rating to Overweight and sets new price target at $86

KeyBanc maintained its Magna International rating to the equivalent of Overweight but changed the price target to $86.0 from $72, in a research...

Jefferies upgrades Medifast [MED] to Buy rating with a $265 price target

Jefferies took its Medifast rating to the equivalent of Buy from Hold, and the price target to $265.0 from $205, in a research...

American Eagle Outfitters [AEO] Upgraded to Outperform at RBC Capital

RBC Capital took its American Eagle Outfitters rating to the equivalent of Outperform from Sector Perform, and the price target to $30.0 from...

KeyBanc reiterates Nike [NKE] rating to Overweight and sets new price target at $180

KeyBanc maintained its Nike rating to the equivalent of Overweight but changed the price target to $180.0 from $174, in a research note...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.